Pay in 4 interest-free payments of $7.41 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
The manufacturers quickly discouraged and filed lawsuits against companies selling alternative versions of the drug with allegations of misleading advertising, unfair competition and deceiving patients
Similarly, some users taking other GLP-1 agonists report period changes , suggesting this is a class-wide effect rather than specific to tirzepatide
Novos Rybelsus sales were approximately $3.5 billion in 2025
Factors such as a high prevalence of diabetes, increasing obesity rates, and a well-established healthcare infrastructure drive the demand for advanced diabetes treatments in this region
:max_bytes(150000):strip_icc()/GettyImages-1299286851-18ab6e02931940ad963dda93851b6dc7.jpg)
US$ 27.53
US$ 26.39
US$ 24.39
